Certain Restricted Stock Units of ImmunoCellular Therapeutics, Ltd. are subject to a Lock-Up Agreement Ending on 16-OCT-2017. These Restricted Stock Units will be under lockup for 90 days starting from 18-JUL-2017 to 16-OCT-2017. Details: The officers, directors and certain of stockholders have agreed that they will not offer, sell, contract to sell, pledge, grant any option to purchase, make any short sale or otherwise dispose of, directly or indirectly any shares of common stock or any securities convertible into or exchangeable for common stock, for a period of 90 days of the underwriting agreement without the prior written consent of Maxim Group LLC.